Previous 10 | Next 10 |
Lineage Acquires Exclusivity for ESI Cell Lines in Spinal Cord Injury and Certain Oncology Indications AgeX Secures Independence to License out ESI Cell Lines as Part of its Collaboration and Licensing Model Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), ...
AgeX Secures Independence to License out ESI Cell Lines as Part of its Collaboration and Licensing Model Lineage Acquires Exclusivity for ESI Cell Lines in Spinal Cord Injury and Certain Oncology Indications AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AG...
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported financial and operating results for the second quarter ended June 30, 2020. AgeX made strides with respect to its newly establishe...
AnPac Bio-Medical Science (NASDAQ: ANPC ) +112% . on validating approved COVID-19 antibody test. More news on: AnPac Bio-Medical Science Co., Ltd., Huttig Building Products, Inc., Plus Therapeutics, Inc., , Read more ...
AgeX Therapeutics (NYSEMKT: AGE ) inks an agreement with Seattle, WA-based Pluristyx under which the latter will manufacture, market and distribute the former's Ready-to-USe and Ready-to-Differentiate clinical-grade ESI brand human embryonic stem cells (hESCs). More news on: AgeX Therape...
Allows industry and academia access to cGMP-grade, NIH-registered AgeX ESI human pluripotent stem cells for development of cellular therapeutics AgeX ESI cell lines are among only a few pluripotent stem cell lines from which derived cell therapy candidates have been granted FDA IND cle...
AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on June 1, 2020 AgeX received a Deficiency Letter from the staff of the NYSE American (the “Exchange”) indic...
AgeX Therapeutics (NYSEMKT: AGE ) inks a non-binding letter of intent with ImStem Biotechnology to obtain from AgeX, a non-exclusive license to use its embryonic stem cell line ESI 053 to derive ImStem’s investigational MSC product IMS001 for development in COVID...
Westwater Resources (NASDAQ: WWR ) +144% on positive independent test results on ULTRA-PMG. More news on: Westwater Resources, Inc., Tenax Therapeutics, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
Emerging preclinical and clinical literature support MSCs may be appropriate to develop for COVID-19 as well as non-COVID-19 ARDS ImStem’s investigational MSC candidate IMS001, for which FDA recently removed a clinical hold on an IND to begin a human study in multiple sclerosis,...
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...